Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan F Lovell

Showing results (231-240 of 241) with videos related to

Pageof 25
Sort By:
Communications Biology|August 1, 2022
Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stagesWei-Chiao Huang, Moustafa T Mabrouk, Luwen Zhou, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 9, 2023
One-year antibody durability induced by EuCorVac-19, a liposome-displayed COVID-19 receptor binding domain subunit vaccine, in healthy Korean subjectsJonathan F Lovell, Kazutoyo Miura, Yeong Ok Baik, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 15, 2023
Irradiated engineered tumor cell-derived microparticles remodel the tumor immune microenvironment and enhance antitumor immunityYan Hu, Yajie Sun, Zhiyun Liao, et al.
Plos One|March 4, 2014
A porphodimethene chemical inhibitor of uroporphyrinogen decarboxylaseKenneth W Yip, Zhan Zhang, Noriko Sakemura-Nakatsugawa, et al.
BMC Medicine|November 29, 2022
Interim analysis from a phase 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccineJonathan F Lovell, Yeong Ok Baik, Seuk Keun Choi, et al.
Nature Communications|April 11, 2024
CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbitsAnnemart Koornneef, Kanika Vanshylla, Gijs Hardenberg, et al.
Nature Communications|January 24, 2026
A stabilized tandem antigen chimera that elicits potent malaria transmission-reducing activityDanton Ivanochko, Kazutoyo Miura, Sophia Hailemariam, et al.
ACS Nano|January 10, 2025
Voices of Nanomedicine: Blueprint Guidelines for Collaboration in Addressing Global Unmet Medical NeedsRajendra Prasad, Arnab Ghosh, Vinay Patel, et al.
Vaccines|April 27, 2026
CEPI Workshop Report: Applying Disease X Vaccine Library and Knowledge Base Approaches to Severe Fever with Thrombocytopenia Syndrome (SFTS)Mitsutaka Kitano, Byoung-Shik Shim, Hitoshi Sasaki, et al.
Immunity|August 17, 2022
Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responsesBrandon McLeod, Moustafa T Mabrouk, Kazutoyo Miura, et al.
Pageof 25

Showing results (231-240 of 241) with videos related to

Sort By:
Pageof 25
Communications Biology|August 1, 2022
Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stagesWei-Chiao Huang, Moustafa T Mabrouk, Luwen Zhou, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 9, 2023
One-year antibody durability induced by EuCorVac-19, a liposome-displayed COVID-19 receptor binding domain subunit vaccine, in healthy Korean subjectsJonathan F Lovell, Kazutoyo Miura, Yeong Ok Baik, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 15, 2023
Irradiated engineered tumor cell-derived microparticles remodel the tumor immune microenvironment and enhance antitumor immunityYan Hu, Yajie Sun, Zhiyun Liao, et al.
Plos One|March 4, 2014
A porphodimethene chemical inhibitor of uroporphyrinogen decarboxylaseKenneth W Yip, Zhan Zhang, Noriko Sakemura-Nakatsugawa, et al.
BMC Medicine|November 29, 2022
Interim analysis from a phase 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccineJonathan F Lovell, Yeong Ok Baik, Seuk Keun Choi, et al.
Nature Communications|April 11, 2024
CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbitsAnnemart Koornneef, Kanika Vanshylla, Gijs Hardenberg, et al.
Nature Communications|January 24, 2026
A stabilized tandem antigen chimera that elicits potent malaria transmission-reducing activityDanton Ivanochko, Kazutoyo Miura, Sophia Hailemariam, et al.
ACS Nano|January 10, 2025
Voices of Nanomedicine: Blueprint Guidelines for Collaboration in Addressing Global Unmet Medical NeedsRajendra Prasad, Arnab Ghosh, Vinay Patel, et al.
Vaccines|April 27, 2026
CEPI Workshop Report: Applying Disease X Vaccine Library and Knowledge Base Approaches to Severe Fever with Thrombocytopenia Syndrome (SFTS)Mitsutaka Kitano, Byoung-Shik Shim, Hitoshi Sasaki, et al.
Immunity|August 17, 2022
Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responsesBrandon McLeod, Moustafa T Mabrouk, Kazutoyo Miura, et al.
Pageof 25